Viewing Study NCT01723657


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-02 @ 5:44 AM
Study NCT ID: NCT01723657
Status: COMPLETED
Last Update Posted: 2012-11-08
First Post: 2012-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)
Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module